TSPYL2 and diabetic kidney disease: Interestingly TSPYL2 is a regulator of cell-cycle arrest induced by TGF-β1 (Epping et al., 2015), which is a major player in DKD pathogenesis mainly because of its potent pro-fibrotic actions (Assmann et al., 2018b).